![Christopher McAleer](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Christopher McAleer worked as Chief Scientist at Hesperos, Inc. and as Chief Scientific Officer at AIM ImmunoTech, Inc. from 2022 to 2024.
Dr. McAleer completed undergraduate studies at West Chester University of Pennsylvania and earned graduate and doctorate degrees from the University of Central Florida.
| Unternehmen | Position | Ende |
|---|---|---|
| AIM IMMUNOTECH INC. | Technik-/Wissenschafts-/F&E-Leiter | 01.02.2024 |
Hesperos, Inc.
 Hesperos, Inc. Pharmaceuticals: OtherHealth Technology Manufactures drugs and medicines | Technik-/Wissenschafts-/F&E-Leiter | - |
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
| Private Unternehmen | 4 |
|---|---|
AIM ImmunoTech, Inc.
 AIM ImmunoTech, Inc. Pharmaceuticals: MajorHealth Technology Researches and develops biopharmaceutical drugs | Health Technology |
University of Central Florida
 University of Central Florida Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
West Chester University of Pennsylvania
 West Chester University of Pennsylvania Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Hesperos, Inc.
Hesperos, Inc. Pharmaceuticals: OtherHealth Technology Manufactures drugs and medicines | Health Technology |
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen
Wählen Sie MarketScreener 
